BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9192983)

  • 1. Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers.
    Shin KY; Kong G; Kim WS; Lee TY; Woo YN; Lee JD
    Br J Cancer; 1997; 75(12):1788-92. PubMed ID: 9192983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder.
    Khan AA; Abel PD; Chaudhary KS; Gulzar Z; Stamp GW; Lalani EN
    Mol Pathol; 2003 Dec; 56(6):353-61. PubMed ID: 14645699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features.
    Lee CC; Yamamoto S; Morimura K; Wanibuchi H; Nishisaka N; Ikemoto S; Nakatani T; Wada S; Kishimoto T; Fukushima S
    Cancer; 1997 Feb; 79(4):780-9. PubMed ID: 9024716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical demonstration of cyclin D1 in bladder cancers as an inverse indicator of invasiveness but not an independent prognostic factor.
    Takagi Y; Takashi M; Koshikawa T; Sakata T; Ohshima S
    Int J Urol; 2000 Oct; 7(10):366-72. PubMed ID: 11144504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification.
    Bringuier PP; Tamimi Y; Schuuring E; Schalken J
    Oncogene; 1996 Apr; 12(8):1747-53. PubMed ID: 8622895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.
    Michalides R; van Veelen N; Hart A; Loftus B; Wientjens E; Balm A
    Cancer Res; 1995 Mar; 55(5):975-8. PubMed ID: 7867006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.
    Nakopoulou L; Constantinides C; Papandropoulos J; Theodoropoulos G; Tzonou A; Giannopoulos A; Zervas A; Dimopoulos C
    Urology; 1995 Sep; 46(3):334-40. PubMed ID: 7660508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.
    Michalides RJ; van Veelen NM; Kristel PM; Hart AA; Loftus BM; Hilgers FJ; Balm AJ
    Arch Otolaryngol Head Neck Surg; 1997 May; 123(5):497-502. PubMed ID: 9158396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p16 and cyclin D1 in bladder cancer and correlation in cancer progression.
    Yang CC; Chu KC; Chen HY; Chen WC
    Urol Int; 2002; 69(3):190-4. PubMed ID: 12372886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy.
    Pelosio P; Barbareschi M; Bonoldi E; Marchetti A; Verderio P; Caffo O; Bevilacqua P; Boracchi P; Buttitta F; Barbazza R; Dalla Palma P; Gasparini G
    Ann Oncol; 1996 Sep; 7(7):695-703. PubMed ID: 8905027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
    Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A
    Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance.
    Levidou G; Saetta AA; Karlou M; Thymara I; Pratsinis H; Pavlopoulos P; Isaiadis D; Diamantopoulou K; Patsouris E; Korkolopoulou P
    J Cancer Res Clin Oncol; 2010 Oct; 136(10):1563-71. PubMed ID: 20174823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urothelium.
    Lopez-Beltran A; Alvarez-Kindelan J; Luque RJ; Blanca A; Quintero A; Montironi R; Cheng L; Gonzalez-Campora R; Requena MJ
    J Pathol; 2008 Jul; 215(3):263-72. PubMed ID: 18452128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients.
    Betticher DC; Heighway J; Thatcher N; Hasleton PS
    Br J Cancer; 1997; 75(12):1761-8. PubMed ID: 9192978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma.
    Zhang YJ; Jiang W; Chen CJ; Lee CS; Kahn SM; Santella RM; Weinstein IB
    Biochem Biophys Res Commun; 1993 Oct; 196(2):1010-6. PubMed ID: 8240318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer.
    Michalides R; Hageman P; van Tinteren H; Houben L; Wientjens E; Klompmaker R; Peterse J
    Br J Cancer; 1996 Mar; 73(6):728-34. PubMed ID: 8611372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
    Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI
    Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.
    Osman I; Scher H; Zhang ZF; Soos TJ; Hamza R; Eissa S; Khaled H; Koff A; Cordon-Cardo C
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2247-51. PubMed ID: 9815621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.